Ponazuiril is an antiprotozoal medication used to treat equine protozoal myeloencephalitis (EPM) caused by Sarcocystis neurona. It may also be used to treat other protozoal parasites such as Toxoplasma spp, coccidia, and Neospora caninum.
Ponazuril
Specifications
Veterinary
Oral
In Development
FEATURED Products
Related Media
New Product Development
Where our FDA approved laboratory begins developing products, formulating and validating methods to ensure quality.
Compliance Audits
Where we audit and champion our partner factories to exceed cGMP standards set by authorities.
Regulatory Services
Where all submissions are filed with the knowledge and experience of our 550+ worldwide approvals on record.